Old Web
English
Sign In
Acemap
>
authorDetail
>
Dilip Gill
Dilip Gill
University of Saskatchewan
FOLFOXIRI
Internal medicine
Bevacizumab
Medicine
Colorectal cancer
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Conversion from unresectable to resectable liver metastases in real-world patients with liver-only metastatic colorectal cancer (mCRC) treated with FOLFOXIRI plus bevacizumab: The Conversion trial.
2021
Journal of Clinical Oncology
Shahid Ahmed
Deborah H. Anderson
Haji I. Chalchal
Lynn Dwernychuk
Dilip Gill
Josh Gitlin
Austin Hammond
Rani Kanthan
Duc Le
J. Lim
Rajan Rakheja
Nazmi Sari
Franco J. Vizeacoumar
Adnan Zaidi
Michael A. J. Moser
Show All
Source
Cite
Save
Citations (1)
Rate of Curative Surgery in Real-world Patients with Unresectable Metastatic Colorectal Cancer Treated with FOLFOXIRI ± Bevacizumab: A Western Canadian Province Experience
2021
Journal of Gastrointestinal Cancer
Tayyaba Bhatti
Michael A. J. Moser
Kiat Tsong Tan
Haji I. Chalchal
Osama Souied
Duc Le
John Shaw
Adnan Zaidi
Dilip Gill
Shahid Ahmed
Show All
Source
Cite
Save
Citations (0)
Rate of conversion from unresectable to resectable metastatic colorectal cancer (mCRC) in real-world patients (RWP) treated with FOLFIXIRI ± bevacizumab: A population-based retrospective cohort study.
2020
Journal of Clinical Oncology
Tayyaba Bhatti
Michael A. J. Moser
Jon Tan
Adnan Zaidi
Duc Le
Haji I. Chalchal
John Shaw
Selliah Kanthan
Mussawar Iqbal
Yigang Luo
Kamal Haider
Tehmina Asif
Dueck Dorie-Anna
Dilip Gill
Nathan Ginther
Shahid Ahmed
Show All
Source
Cite
Save
Citations (0)
1